From
StayCurrentMD
Case-Based Journal Review: Congenital Diaphragmatic Hernia 2023
With Dr. Fernando Bullettin · hosted by Dr. Cecilia Gigena & Dr. Jose Campos & Dr. Todd Ponsky
Chapter 1 of 6 · Evidence & Research
FETO efficacy
Fetal intervention (FETO) for severe CDH
Expert statements on this page
No expert statements were drawn from this page.
Host summaries · secondary, not cited in answers
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
CDH - MIS vs. Open: Update Course 2015
5 min · Published Nov 2015
Video
Improving Outcomes for Congenital Diaphragmatic Hernia (CDH): Protocol Changes at Cincinnati Children's
5 min · Published Jun 2026
Video
Inside a FETO Procedure: Fetoscopic Balloon Tracheal Occlusion with Dr. Beth Rymeski
4 min · Published Jul 2026
Video
BOB Ped Surg 2023 - Shelby Sferra, AAP - Presentation
5 min · Published Feb 2023
Video
BOB in Ped Surg 2023 - AAP Winner - Shelby Sferra, MD
11 min · Published Feb 2023
Video
CDH-ECMO - VV vs. VA - Repair on ECMO: Update Course 2015
10 min · Published Nov 2015
Only a few other public items share this expert — go deeper there →
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
Video
Tricuspid valve surgery in transposition of the great arteries with a systemic right ventricle
46 s · Published May 2026
What the experts said
Centers with high CDH volume performing ECMO achieve survival rates of approximately 50% or more in severe CDH patients.
In Europe, some maternal-fetal medicine centers perform FETO but then transfer patients to separate centers for delivery and neonatal care, creating a separation between fetal intervention and postnatal ECMO expertise.
FETO does not eliminate the need for ECMO; both interventions can be performed in the same patient.
One Chilean center's protocol involves ECMO cannulation at 6-8 hours of life followed by CDH repair 8-10 hours after cannulation.
For CDH repair on ECMO, anticoagulation management involves decreasing heparin and using Amicar before, during, and after surgery, with neonatologists managing the protocol.
At least four published reports confirm the data showing benefit of early repair on ECMO, representing a practice change in the field.
Prolonged operative time required for thoracoscopic CDH repair in babies requiring inotropic support or special ventilation (with increased CO2 and decreased pH) is detrimental to the patient.
Possible technical factors contributing to higher recurrence in thoracoscopic CDH repair include: insufficient scar formation from lack of tissue opposition, inadequate unfurling of the diaphragm, taking bites at the same tissue level creating a bundle that can pull away, or insufficient number of sutures.
A transverse abdominal incision (rather than subcostal) allows intraoperative decision-making between flap and mesh repair based on defect size, making mesh repair slightly more difficult but not impossible.
Biological patches are not designed to function as a bridge and should not be used alone for CDH repair; they can be used to reinforce a synthetic patch by placing on top.
The 80% chest wall deformity rate with synthetic patches may be inflated by inclusion of skeletal deformities inherent to CDH disease rather than caused by the patch itself.
Type D CDH defects (large defects) are very rare.
One surgeon performs fundoplication at initial CDH repair selectively in patients with type D defects who are on ECMO.
In one surgeon's experience with selective fundoplication in type D ECMO patients, none have required subsequent fundoplication surgery, representing definitive repair of both CDH and reflux.
FETO (fetal endoscopic tracheal occlusion) increases general survival in moderate and severe CDH, with statistically significant benefit specifically in severe CDH cases, based on meta-analysis of 4 randomized controlled trials with 341 patients.
The apparent benefit of FETO depends on the quality of the comparison center's ECMO results; centers with moderate or poor ECMO outcomes will show larger apparent FETO benefits.
Boston Children's Hospital retrospective cohort study found that on-ECMO repair demonstrated lower mortality rate, lower hazard ratio, and lower incidence of non-repair compared to post-ECMO repair.
In the Boston study's second analysis arm, early repair on ECMO was associated with lower mortality, lower hazard ratio, and lower incidence of non-repair compared to late repair on ECMO.
Meta-analysis from Canada (2014) found that minimally invasive CDH repair has higher recurrence rates (especially when patch is required) and longer operative time compared to open repair.
The same meta-analysis found open CDH repair was associated with more postoperative ventilator time and higher mortality rates compared to MIS repair.
University of Colorado study (2019) of 52 patients found that muscle flap repair leads to lower recurrence rates compared to patch repair in CDH cases.
The lower recurrence rate with flap repair may be due to the flap's ability to grow over time with the child.
UK systematic review and meta-analysis of 986 CDH patients (226 biological patches, 760 synthetic) found biological patches had a recurrence rate of 30.3% versus 16.7% for synthetic patches.
In the UK patch study, biological patches had adhesion rates between 7-35% while synthetic patches had adhesion rates between 4-29%.
Synthetic patches were associated with chest wall deformities in 80% of cases in the UK meta-analysis.
French prospective cohort study (JPS 2022) of 762 CDH neonates found that 81 underwent fundoplication (either preventive or curative).
The French study found that preventive fundoplication during patch repair does not decrease the need for future curative fundoplication and is associated with adverse GI outcomes.
In the French fundoplication study, patients who received fundoplication had failure-to-thrive rates of 81% versus 51% in those who did not receive fundoplication.